Live
- Sunny turns up the heat
- ‘Thandel’ first single ‘Bujji Thalli’ to drop soon
- ‘Thalapathi’ set for grand re-release on Rajinikanth’s 74th birthday
- Shahid Kapoor’s ‘Ashwatthama’ kept on hold due to budget constraints
- ‘Drinker Sai’ teaser: Attracts youth
- Netflix Outage in India and US Ahead of Tyson vs Paul Match
- Police Intensify Investigation into Lagacharla Attack on Officers; Eight More Detained
- Google Docs Introduces AI-Powered Clip Art Generator with Gemini
- LIC sets up stall at India Int’l Trade Fair
- Celebrating journalism and its role in society
iGenetic develops RT-PCR kits for Covid-19 testing
Mumbai-based specialty diagnostic major iGenetic Diagnostics and Thane-based Biogenomics jointly developed RT-PCR testing kits with 100 per cent concordance to true positives and true negatives and have received approval from Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
Hyderabad: Mumbai-based specialty diagnostic major iGenetic Diagnostics and Thane-based Biogenomics jointly developed RT-PCR testing kits with 100 per cent concordance to true positives and true negatives and have received approval from Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
The RT-PCR kit, considered to be the gold standard for diagnosis of Covid-19, has jointly been developed by iGenetic & Biogenomics and Biogenomics is working on manufacturing and distribution across the country. The kits are expected to be available in the market within a few weeks. The availability of the kits will boost testing capabilities in the Hyderabad which has nearly 2,891 confirmed cases of coronavirus that has claimed 92 lives.
"India has already began testing one lakh people a day and our kits will offer a boost to the efforts of ramping up the testing capability further. The RT-PCR test kits have been approved after satisfying the stringent guidelines of ICMR and NIV that squeeze the chances of a false positive or a false negative to zero. These kits are better than global kits in terms of quality, adaptability, and price," said Arunima Patel, founder & CEO, iGenetic Diagnostics.
